Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1

Author： Chiurchiù Valerio   Maccarrone Mauro   Orlacchio Antonio  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.2, 2012-02, pp. : 181-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic compounds: patent evaluation of WO2011011652A1

By Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1491-1495

Informa Healthcare

Access to resources Recommend Favorite

Casein hydrolysate for uterine infection treatment: a patent evaluation (WO2011132191)

By Cozza Giorgio  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 575-578

Informa Healthcare

Access to resources Recommend Favorite

Antagonists of IL-1R: a patent evaluation (WO2012122985)

By Sette Claudio  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 911-914

Informa Healthcare

Access to resources Recommend Favorite

Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1

By Winum Jean-Yves  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 757-760

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease

By Tábi Tamás   Szökő Éva   Vécsei László   Magyar Kálmán  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 629-636

Informa Healthcare

Access to resources Recommend Favorite